- MARTIN SMEGMA AT IT AGAIN http://mobile.nytimes.com/2015/12/12/business/martin-shkrelis-latest-plan-to-sharply-raise-drug-price-prompts-outcry.html?_r=0&referer=https://www.google.com/ 21 comments wallstreetbets
- Martin Shkreli's company is again sharply increasing the price of a decades-old drug for a serious infectious disease. This time it's the Chagas disease, a parasitic infection that can cause potentially lethal heart problems. http://www.nytimes.com/2015/12/12/business/martin-shkrelis-latest-plan-to-sharply-raise-drug-price-prompts-outcry.html 1814 comments worldnews
Linking pages
- Shkreli vs. Holmes: 2 Frauds, 2 Divergent Outcomes. Were They Fair? - The New York Times https://www.nytimes.com/2018/03/22/business/shkreli-holmes-fraud.html 31 comments
- First FDA-Approved Drug For Chagas Raises Price Concerns : Shots - Health News : NPR http://www.npr.org/sections/health-shots/2017/09/10/547351794/drug-for-neglected-chagas-disease-gains-fda-approval-amid-price-worries 0 comments
- In comeback bid, Shkreli’s old company gets OK to buy life-saving drug | Ars Technica http://arstechnica.com/science/2016/02/in-comeback-bid-shkrelis-old-company-gets-ok-to-buy-life-saving-drug/ 0 comments
- We are all Martin Shkreli. In the wake of tragedy, you hear it a… | by John Skylar, PhD | Medium https://medium.com/the-lighthouse/we-are-all-martin-shkreli-c77ebad1de2a#.8dcd9mbt2 0 comments
- Martin Shkreli’s other pharma company is dramatically collapsing | Ars Technica http://arstechnica.com/science/2015/12/martin-shkrelis-other-pharma-company-is-dramatically-collapsing/ 0 comments
Linked pages
Related searches:
Search whole site: site:mobile.nytimes.com
Search title: Martin Shkreli’s Latest Plan to Sharply Raise Drug Price Prompts Outcry - The New York Times
See how to search.